Reported Earlier, Gilead Sciences Announces $1.675B Acquisition Of Ouro Medicines With Up To $500M Milestones To Expand T Cell Engager Autoimmune Disease Portfolio

Benzinga Newsdesk www.benzinga.com Positive 88.5%

Neg 0% Neu 0% Pos 88.5%

Comments

No comments yet. Be the first!